Scott Dahlbeck
Founder chez KIROMIC BIOPHARMA, INC.
Fortune : 40 806 $ au 31/03/2024
Profil
Scott Dahlbeck is the founder and currently holds the position of Chief of Staff at Kiromic Biopharma, Inc., a company he founded in 2006.
He is also the founder and currently holds the position of President & Chief Medical Officer at Kiromic, Inc., a company he founded in 2013.
Dr. Dahlbeck has a doctorate degree from the University of Nebraska Medical Center and The University of Texas Health Science Center at Houston.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KIROMIC BIOPHARMA, INC.
1,11% | 21/03/2024 | 14 318 ( 1,11% ) | 40 806 $ | 31/03/2024 |
Postes actifs de Scott Dahlbeck
| Sociétés | Poste | Début |
|---|---|---|
| KIROMIC BIOPHARMA, INC. | Founder | 06/08/2006 |
Kiromic, Inc.
 Kiromic, Inc. Medical/Nursing ServicesHealth Services Kiromic, Inc. is a biotech company that has discovered a breakthrough technology called the Diamond Artificial Intelligence platform. It serves as the foundation for Kiromic’s new drug discoveries through novel target identification. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck in 2013 and is headquartered in Houston, TX. | Founder | 01/01/2013 |
Formation de Scott Dahlbeck
| University of Nebraska Medical Center | Doctorate Degree |
| The University of Texas Health Science Center at Houston | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KIROMIC BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kiromic, Inc.
Kiromic, Inc. Medical/Nursing ServicesHealth Services Kiromic, Inc. is a biotech company that has discovered a breakthrough technology called the Diamond Artificial Intelligence platform. It serves as the foundation for Kiromic’s new drug discoveries through novel target identification. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck in 2013 and is headquartered in Houston, TX. | Health Services |
